: Praised for its robust drug pipeline and use of AI in cancer treatments.

: He remains bullish but currently advises waiting for a pullback.

: There is a documented increase in short-selling activity immediately following his buy recommendations as professional investors exploit the temporary overpricing. Recent "Buy" Recommendations (April 2026)

: Studies indicate these initial gains are often transitory. Prices typically reverse within 3 to 30 days, suggesting the bounce is driven by uninformed trading volume rather than new fundamental value.